These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10402415)

  • 1. Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool.
    Meirow D; Lewis H; Nugent D; Epstein M
    Hum Reprod; 1999 Jul; 14(7):1903-7. PubMed ID: 10402415
    [TBL] [Abstract][Full Text] [Related]  

  • 2. AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice.
    Sonigo C; Beau I; Grynberg M; Binart N
    FASEB J; 2019 Jan; 33(1):1278-1287. PubMed ID: 30113879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure.
    Pascuali N; Scotti L; Di Pietro M; Oubiña G; Bas D; May M; Gómez Muñoz A; Cuasnicú PS; Cohen DJ; Tesone M; Abramovich D; Parborell F
    Hum Reprod; 2018 May; 33(5):844-859. PubMed ID: 29534229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The GnRH antagonist cetrorelix reduces cyclophosphamide-induced ovarian follicular destruction in mice.
    Meirow D; Assad G; Dor J; Rabinovici J
    Hum Reprod; 2004 Jun; 19(6):1294-9. PubMed ID: 15117898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide.
    Luan Y; Edmonds ME; Woodruff TK; Kim SY
    J Endocrinol; 2019 Feb; 240(2):243-256. PubMed ID: 30530902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose metronomic delivery of cyclophosphamide is less detrimental to granulosa cell viability, ovarian function, and fertility than maximum tolerated dose delivery in the mouse.
    Dynes J; Osz K; Hooper A; Petrik J
    Biol Reprod; 2017 Sep; 97(3):449-465. PubMed ID: 29024988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Collaborative work on evaluation of ovarian toxicity. 7) Effects of 2- or 4- week repeated dose studies and fertility study of cyclophosphamide in female rats.
    Sato M; Shiozawa K; Uesugi T; Hiromatsu R; Fukuda M; Kitaura K; Minami T; Matsumoto S
    J Toxicol Sci; 2009; 34 Suppl 1():SP83-9. PubMed ID: 19265293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of a gonadotropin-releasing hormone analogue on cyclophosphamide-induced ovarian toxicity in adult mice.
    Kishk EA; Mohammed Ali MH
    Arch Gynecol Obstet; 2013 May; 287(5):1023-9. PubMed ID: 23224696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of cyclophosphamide-induced ovarian damage by concomitant administration of GnRHa in mice: a dose-dependent relationship?
    Yüce MA; Balkanli Kaplan P; Gücer F; Doğanay L; Altaner S; Canda T; Yardim T
    Eur J Gynaecol Oncol; 2004; 25(5):628-31. PubMed ID: 15493183
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the effects of bone marrow derived mesenchymal stem cells and ovarian stromal stem cells on follicular maturation in cyclophosphamide induced ovarian failure in rats.
    Besikcioglu HE; Sarıbas GS; Ozogul C; Tiryaki M; Kilic S; Pınarlı FA; Gulbahar O
    Taiwan J Obstet Gynecol; 2019 Jan; 58(1):53-59. PubMed ID: 30638481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapamycin Prevents cyclophosphamide-induced Over-activation of Primordial Follicle pool through PI3K/Akt/mTOR Signaling Pathway in vivo.
    Zhou L; Xie Y; Li S; Liang Y; Qiu Q; Lin H; Zhang Q
    J Ovarian Res; 2017 Aug; 10(1):56. PubMed ID: 28814333
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility.
    Nguyen QN; Zerafa N; Liew SH; Morgan FH; Strasser A; Scott CL; Findlay JK; Hickey M; Hutt KJ
    Cell Death Dis; 2018 May; 9(6):618. PubMed ID: 29795269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of SDF-1/CXCR4 and cytokines in the development of ovary injury in chemotherapy drug induced premature ovarian failure mice.
    Luo Q; Yin N; Zhang L; Yuan W; Zhao W; Luan X; Zhang H
    Life Sci; 2017 Jun; 179():103-109. PubMed ID: 28478265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does controlled ovarian stimulation prior to chemotherapy increase primordial follicle loss and diminish ovarian reserve? An animal study.
    Maman E; Prokopis K; Levron J; Carmely A; Dor J; Meirow D
    Hum Reprod; 2009 Jan; 24(1):206-10. PubMed ID: 18854408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinase-independent inhibition of cyclophosphamide-induced pathways protects the ovarian reserve and prolongs fertility.
    Bellusci G; Mattiello L; Iannizzotto V; Ciccone S; Maiani E; Villani V; Diederich M; Gonfloni S
    Cell Death Dis; 2019 Sep; 10(10):726. PubMed ID: 31562295
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats.
    Tsuyoshi H; Orisaka M; Fukuda S; Hattori K; Tsang BK; Yoshida Y
    Steroids; 2015 Jan; 93():1-7. PubMed ID: 25449767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of AKT and FOXO3 in preventing ovarian toxicity induced by cyclophosphamide.
    Zhang BF; Hu Y; Liu X; Cheng Z; Lei Y; Liu Y; Zhao X; Mu M; Yu L; Cheng ML
    PLoS One; 2018; 13(8):e0201136. PubMed ID: 30071053
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ovaries of patients recently treated with alkylating agent chemotherapy indicate the presence of acute follicle activation, elucidating its role among other proposed mechanisms of follicle loss.
    Shai D; Aviel-Ronen S; Spector I; Raanani H; Shapira M; Gat I; Roness H; Meirow D
    Fertil Steril; 2021 May; 115(5):1239-1249. PubMed ID: 33485607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations.
    Meirow D; Epstein M; Lewis H; Nugent D; Gosden RG
    Hum Reprod; 2001 Apr; 16(4):632-7. PubMed ID: 11278209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Collaborative work on evaluation of ovarian toxicity. 5) Two- or four-week repeated-dose studies and fertility study of busulfan in female rats.
    Sakurada Y; Kudo S; Iwasaki S; Miyata Y; Nishi M; Masumoto Y
    J Toxicol Sci; 2009; 34 Suppl 1():SP65-72. PubMed ID: 19265291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.